Dr Reddy's launches lipid controlling drug in USA market

Pharma major Dr Reddy's Laboratories today said it has launched Fenofibrate capsules, a therapeutic

RELATED ARTICLES

equivalent generic version of Antara capsules, in the USA market.

The drug which is indicated to reduce cholesterol and triglycerides (fatty acids) in the blood was approved by the United States Food & Drug Administration (USFDA), DRL said in a statement.

The Antara (fenofibrate) capsules brand and generic had U.S. Sales of approximately $74 Million MAT for the most recent twelve months ending in February 2014 according to IMS Health.

Dr Reddy’s Fenofibrate capsules, USP 43 mg is available in bottle counts of 30, and 130 mg are available in bottle counts of 30 and 90, the drug maker said.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • Rejigged FIIS could help our farmers tide over yet another dull monsoon

    India is an agrarian economy with one-third of its population depending on the agriculture sector directly.

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

TODAY'S COLUMNS

Arun Kumar Jain

Nations need both guns and grains

As Buddha said: “Words without context have no meaning.” Quoting ...

Kuruvilla Pandikattu SJ

Bored out of your wits? Get creative

Have you been truly bored? “So bored your mind churns ...

Gautam Gupta

Indian designers can learn a lot from Benetton

I was reading an article in the magazine about Benetton ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture